Home
>
National Drug Code (NDC)
>
PROLASTIN-C
PROLASTIN-C - 13533-700-02 - (alpha-1-proteinase inhibitor human)
Drug Information of PROLASTIN-C
| Product NDC: | 13533-700 |
| Proprietary Name: | PROLASTIN-C |
| Non Proprietary Name: | alpha-1-proteinase inhibitor human |
| Active Ingredient(s): | & nbsp; alpha-1-proteinase inhibitor human |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PROLASTIN-C
| Product NDC: | 13533-700 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103174 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19871202 |
Package Information of PROLASTIN-C
| Package NDC: | 13533-700-02 |
| Package Description: | 1 KIT in 1 CARTON (13533-700-02) * 20 mL in 1 VIAL, SINGLE-DOSE * 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of PROLASTIN-C
| NDC Code | 13533-700-02 |
| Proprietary Name | PROLASTIN-C |
| Package Description | 1 KIT in 1 CARTON (13533-700-02) * 20 mL in 1 VIAL, SINGLE-DOSE * 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 13533-700 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | alpha-1-proteinase inhibitor human |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19871202 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
